Biolidics to launch Covid-19 rapid test kit in April
Add BT as a preferred sourceDeeperDive is a beta AI feature. Refer to full articles for the facts.
Singapore
CANCER-diagnostics company Biolidics on Monday announced that it has launched a rapid test kit for Covid-19, which is expected to be available by the end of April.
Biolidics said its novel corona-virus test can detect Covid-19 using serum, plasma or whole blood samples with an accuracy of more than 95 per cent in 10 minutes, and has received provisional authorisation from Singapore's Health Sciences Authority for use here.
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Copyright SPH Media. All rights reserved.
TRENDING NOW
Air India asks Tata, Singapore Airlines for funds after US$2.4 billion loss
Beijing’s calculated silence on the Iran war
China pips the US if Asean is forced to choose, but analysts warn against reading it like a sports result
Richard Eu on how core values, customers keep Singapore’s TCM chain Eu Yan Sang relevant
